Boots Sore Throat Relief Dual Action 2.4mg lozenges black cherry

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Hexylresorcinol

可用日期:

The Boots Company Plc

ATC代码:

R02AA12

INN（国际名称）:

Hexylresorcinol

剂量:

2.4mg

药物剂型:

Lozenge

给药途径:

Oromucosal

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 12030300; GTIN: 5045095918316

资料单张

Sore Throat Relief Double Action 2.4mg Lozenges Cherry
Flavour
(Hexylresorcinol)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.

Always take this medicine exactly as described in this leaflet

Keep this leaflet. You may need to read it again

Ask your pharmacist if you need more information or advice

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet

You must contact a doctor if your symptoms worsen or do not improve
WHAT IS IN THIS LEAFLET
1.
What this medicine is and what it is used for
2.
Before you take this medicine
3.
How to take this medicine
4.
Possible side effects
5.
How to store this medicine
6.
Contents of the pack and other information
1.
WHAT THIS MEDICINE IS AND WHAT IT IS USED FOR
These lozenges are recommended for sore throats and associated pain.
The active
ingredient hexylresorcinol is an antiseptic which combats the bacteria
that cause sore
throats.
It also acts as an anaesthetic to bring soothing relief of pain and
discomfort.
2.
BEFORE YOU TAKE THIS MEDICINE
X DO NOT

Take these lozenges if you are hypersensitive (allergic) to the active
ingredient or any other
ingredients in this medicine (listed in section 6)

Give to children under 6 years
PREGNANCY AND BREAST-FEEDING
Ask your doctor or pharmacist for advice before taking any medication.
If you are pregnant, or think you may be pregnant, please ask your
doctor or pharmacist
before using these lozenges. They may not be suitable for you.
IMPORTANT INFORMATION ABOUT SOME OF THE INGREDIENTS OF THIS MEDICINE

Each lozenge contains a total of 2.4 g of sucrose and glucose. This
should be taken into
account if you have diabetes mellitus. If you have been told by your
doctor that you have an
intolerance to some sugars, contact your doctor before taking the
product.

The colour carmoisine (E122) in this medicine may cause allergic
reactions
3.
HOW TO TAKE THIS MEDIC

产品特点

BOOTS SORE THROAT RELIEF DUAL ACTION LOZENGES
BLACK CHERRY FLAVOUR
Summary of Product Characteristics Updated 20-Aug-2015 | THE BOOTS
COMPANY PLC
1. Name of the medicinal product
Boots Sore Throat Relief Dual Action Lozenges Black Cherry Flavour
2. Qualitative and quantitative composition
Each lozenge contains Hexylresorcinol 2.4mg
For excipients see Section 6.1
3. Pharmaceutical form
Lozenge
A round red lozenge
4. Clinical particulars
4.1 Therapeutic indications
As an antiseptic and local anaesthetic for the relief of sore throat
and its associated pain.
4.2 Posology and method of administration
For oral administration.
Adults, the elderly and children 6 years and over: One lozenge
dissolved slowly in the mouth every three
hours or as required.
Do not take more than 12 lozenges in 24 hours.
Not to be given to children under 6 years.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
4.4 Special warnings and precautions for use
The label will convey:
Keep out of the reach and sight of children.
If symptoms persist consult your doctor.
Not to be given to children under 6 years.
This product is unsuitable in hereditary fructose intolerance,
glucose-galactose malabsorption syndrome,
or sucrase-isomaltase deficiency.
4.5 Interaction with other medicinal products and other forms of
interaction
None known.
4.6 Pregnancy and lactation
There is lack of evidence of safety of the product in human pregnancy
and in animals, but hexylresorcinol
has been used widely in lozenges for many years without apparent ill
consequence. However, as with all
medicines, caution should be exercised during pregnancy and lactation.
4.7 Effects on ability to drive and use machines
None known.
4.8 Undesirable effects
None known.
REPORTING OF SUSPECTED ADVERSE REACTIONS
Reporting suspected adverse reactions after authorisation of the
medicinal product is important. It allows
continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are
asked to report any suspected adverse reactions via th